Albert Benjamin 4
4 · Health Catalyst, Inc. · Filed Jun 15, 2026
Research Summary
AI-generated summary of this filing
Health Catalyst (HCAT) CEO Albert Benjamin Sells 34,485 Shares
What Happened
Albert Benjamin, CEO and director of Health Catalyst, sold 34,485 shares on June 10, 2026 at $1.69 per share, producing gross proceeds of $58,342. The sale was a mandatory "sell-to-cover" to satisfy tax withholding tied to the vesting of restricted stock units (RSUs), not a discretionary open-market sale.
Key Details
- Transaction date: 2026-06-10; price: $1.69 per share; shares sold: 34,485; proceeds: $58,342.
- Transaction type/code: F (tax withholding — sell-to-cover).
- Footnote: The sale was required to cover tax withholding on RSU vesting and was mandated by the issuer's equity plan (not a voluntary trade).
- Filing: Form 4 filed 2026-06-15 for the 2026-06-10 transaction; filing is marked late (filed after the typical 2-business-day window).
- Shares owned after transaction: Not specified in this filing.
Context
A sell-to-cover is a routine administrative transaction to pay taxes when equity awards vest and does not necessarily reflect the insider’s view on the company. For retail investors, purchases or voluntary sales usually carry more information about management sentiment than mandatory tax-withholding disposals.
Insider Transaction Report
Form 4
Albert Benjamin
DirectorCEO
Transactions
- Tax Payment
Common Stock
[F1]2026-06-10$1.69/sh−34,485$58,342→ 1,423,971 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Signature
/s/ Benjamin Landry, as Attorney-in-Fact|2026-06-15